secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0001356576-23-000063
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus announces Q3 2023 earnings release and call on Nov 8
-------------------------------------------------------------

- Earnings results after market close on Nov 8, 2023; call at 4:30 p.m. ET.
- President/CEO Jack Khattar and CFO Tim Dec to host conference call.
- No financial results disclosed; this is a scheduling announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657623000063/0001356576-23-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657623000063/supn-20231025.htm
  HTML page:      https://secwatch.observer/filing/0001356576-23-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer